Covid-19 Vaccine (AstraZeneca) Declared SAFE Following Out-scare from Over 18 European Countries.
A pharmacist administers the AstraZeneca COVID-19 vaccine to a patient in a pharmacy in Roubaix as part of the coronavirus disease (COVID-19) vaccination campaign in France, March 15, 2021.
- The European Medicines Agency’s statement followed an investigation of blood clots in vaccinated people.
- Eighteen countries that had paused use of the shot could now lift their suspensions.
AstraZeneca and Oxford University’s COVID-19 vaccine is safe, and its benefits outweigh its risks, the European regulator said Thursday.
The European Medicines Agency (EMA) said in a press briefing that AstraZeneca’s vaccine was not associated with a higher risk of blood clots, following an investigation into reports that people who had received the vaccine developed clots.
The number of clots reported after vaccination, both in trial studies and during the shot’s rollout, was lower than that expected in the general population, the EMA said.
However, the EMA said it still could not definitively rule out a link between the vaccine and the reported rare cases of very serious clotting, specifically blood clots associated with low levels of blood platelets. It had launched additional reviews on the matter, it said.
At least 18 countries worldwide – including Sweden, Germany, and France – had suspended the vaccine as a precaution, pending the EMA’s investigation. Many of those countries said that suspensions would be lifted if the EMA concluded the vaccine was safe.
“The benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects,” the EMA said – a view that the regulator has maintained throughout.
EMA Executive Director Emer Cooke said that she would be “vaccinated tomorrow.”